EX-1 2 d28069dex1.htm EX-1

EX-1

Exhibit 1

Joint Filing Agreement

AGREEMENT dated as of September 24, 2015, by and among WPP Luxembourg Gamma Three S.à r.l. and WPP plc (collectively, the “Parties”).

Each of the Parties hereto represents to the other Parties that it is eligible to use Schedule 13D to report its beneficial interest in the common stock of OptimizeRx Corporation (“Schedule 13D”) and it will file the Schedule 13D on behalf of itself.

Each of the Parties agrees to be responsible for the timely filing of the Schedule 13D and any and all amendments thereto and for the completeness and accuracy of the information concerning itself contained in the Schedule 13D, and the other Parties to the extent it knows or has reason to believe that any information about the other Parties is inaccurate.

		WPP LUXEMBOURG GAMMA THREE S.À R.L.
				By:		/s/ Anne Ehrismann
				Name: Anne Ehrismann
				Title: Manager
				By:		/s/ Thierry Lenders
				Name: Thierry Lenders
				Title: Manager
		WPP PLC
				By:		/s/ Paul W.G. Richardson
				Name: Paul W.G. Richardson
				Title: Chief Financial Officer